Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cis Nucleosides. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1297553C reveals a catalytic 2-step route for cis-nucleosides. Enhances yield and stereocontrol for antiviral drug manufacturing supply chains.